标题
Tuberculosis Drug Discovery: Challenges and New Horizons
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2022-05-25
DOI
10.1021/acs.jmedchem.2c00227
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas
- (2022) Samantha Ottavi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterial Membranes as Actionable Targets for Lipid-Centric Therapy in Tuberculosis
- (2022) Biswabrata Modak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
- (2022) Rong Yao et al. Microbiology Spectrum
- An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
- (2022) Kiel Hards et al. Communications Biology
- Discovery of Benzofuroxan Derivatives as Potent Agents Active Against Multidrug‐Resistant Mycobacterium tuberculosis
- (2021) Guilherme Felipe Dos Santos Fernandes et al. ChemMedChem
- QcrB in Mycobacterium tuberculosis : The new drug target of antitubercular agents
- (2021) Aparna Bahuguna et al. MEDICINAL RESEARCH REVIEWS
- Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
- (2021) Peter C. Ray et al. ACS Omega
- Comparative efficacy of the novel diarylquinoline TBAJ-587 and bedaquiline against a resistant Rv0678 mutant in a mouse model of tuberculosis
- (2021) Jian Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis
- (2021) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of N ‐heterocycles towards anti‐tubercular drug discovery (2014–2019); predicted and reengineered molecular frameworks
- (2021) Dorababu Atukuri et al. DRUG DEVELOPMENT RESEARCH
- Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
- (2021) Simon Tiberi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Strategies to Combat Multi-Drug Resistance in Tuberculosis
- (2021) Vinayak Singh et al. ACCOUNTS OF CHEMICAL RESEARCH
- Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains
- (2021) Akanksha Sharma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
- (2021) Pengxu Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection
- (2021) Ravindra Jadhav et al. PLoS One
- Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
- (2021) Sangmi Oh et al. Frontiers in Cellular and Infection Microbiology
- Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review
- (2021) Klaudia T. Angula et al. Pharmaceuticals
- Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 inhibitors TBA-7371, PBTZ169 and OPC-167832
- (2021) Gregory T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis
- (2021) Wei Yu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo activity of oxazolidinone candidate OTB-658 against Mycobacterium tuberculosis
- (2021) Shaochen Guo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits
- (2021) Oluwaseun Egbelowo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads
- (2021) Xiao Wang et al. BIOORGANIC CHEMISTRY
- Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
- (2021) Barbara Bosch et al. CELL
- Contezolid: First Approval
- (2021) Sheridan M. Hoy DRUGS
- Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs
- (2021) Qianqian Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
- (2021) Matthew B. McNeil et al. MOLECULAR MICROBIOLOGY
- The Tuberculosis Drug Accelerator at year 10: what have we learned?
- (2021) Bree B. Aldridge et al. NATURE MEDICINE
- A multi-targeting pre-clinical candidate against drug-resistant tuberculosis
- (2021) Parvinder Kaur et al. TUBERCULOSIS
- The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB
- (2021) Schara Safarian et al. Nature Communications
- Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs
- (2021) Richard C. Lavin et al. PLOS BIOLOGY
- Structure, In Vivo Detection, and Antibacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate
- (2021) Satish R. Malwal et al. ACS Infectious Diseases
- Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
- (2021) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis
- (2021) Peng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
- (2021) Caroline Wilson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of mycobacterial CIII2CIV2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203)
- (2021) David J Yanofsky et al. eLife
- Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
- (2021) Shan Zhou et al. eLife
- Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
- (2020) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adduct formation of delamanid with NAD in mycobacteria
- (2020) Mikayo Hayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The quest for the holy grail: new antitubercular chemical entities, targets and strategies
- (2020) Stanislav Huszár et al. DRUG DISCOVERY TODAY
- Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis
- (2020) Wenting Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
- (2020) Jennifer A. Borthwick et al. JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds
- (2020) Garrett C. Moraski et al. PLoS One
- Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase
- (2020) Karolina Michalska et al. PROTEIN SCIENCE
- New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
- (2020) Andréanne Lupien et al. PLoS Pathogens
- Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine–D-Alanine Ligase With a Novel Inhibitor, IMB-0283
- (2020) Jianzhou Meng et al. Frontiers in Microbiology
- Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity
- (2020) Baptiste Villemagne et al. ACS Infectious Diseases
- Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
- (2020) Giulia Degiacomi et al. Applied Sciences-Basel
- Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model
- (2020) Deepak V. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
- (2020) Norimitsu Hariguchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New antituberculosis drugs targeting the respiratory chain
- (2020) Qian Li et al. CHINESE CHEMICAL LETTERS
- Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis
- (2020) Vadim Makarov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors
- (2020) Olga Balabon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
- (2020) José E. S. Nunes et al. MOLECULES
- Telacebec (Q203), a New Antituberculosis Agent
- (2020) Veronique R. de Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Pyrazinamide triggers degradation of its target aspartate decarboxylase
- (2020) Pooja Gopal et al. Nature Communications
- Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite
- (2020) Fraser Cunningham et al. ACS Infectious Diseases
- Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition
- (2020) Ming Li et al. ACS Infectious Diseases
- Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
- (2020) Catherine Vilchèze Applied Sciences-Basel
- Development of Delpazolid for the Treatment of Tuberculosis
- (2020) Young Lag Cho et al. Applied Sciences-Basel
- Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis
- (2020) Caroline Shi-Yan Foo et al. Applied Sciences-Basel
- Development of Macozinone for TB treatment: An Update
- (2020) Vadim Makarov et al. Applied Sciences-Basel
- Multi-drug resistant tuberculosis with simultaneously acquired-drug resistance to bedaquiline and delamanid
- (2020) Takashi Yoshiyama et al. CLINICAL INFECTIOUS DISEASES
- Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents
- (2020) Apeng Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis
- (2020) Hongyi Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease
- (2020) J. Shaun Lott BIOCHEMICAL SOCIETY TRANSACTIONS
- Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection
- (2020) P.C. de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agent
- (2020) Guanghai Jin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis
- (2020) Bei Shi Lee et al. EMBO Molecular Medicine
- Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline
- (2020) Hui Guo et al. NATURE
- Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis
- (2019) Maria João Catalão et al. Frontiers in Microbiology
- The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
- (2019) Yang Liu et al. Nature Communications
- Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents
- (2019) Xianglong Hu et al. ACS Medicinal Chemistry Letters
- Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
- (2019) Elaine Ballinger et al. SCIENCE
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II
- (2019) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model
- (2019) Gregory T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis
- (2019) Jian Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo
- (2019) Ye Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advancing the therapeutic potential of indoleamides for tuberculosis
- (2019) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
- (2019) Hamish S. Sutherland et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A critical review of HPLC-based analytical methods for quantification of Linezolid
- (2019) Guilherme Felipe dos Santos Fernandes et al. CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
- Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy
- (2019) Ya-Juan Cheng et al. MOLECULES
- Trends in clinical success rates and therapeutic focus
- (2019) Helen Dowden et al. NATURE REVIEWS DRUG DISCOVERY
- Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid
- (2019) Van den Bossche An et al. TUBERCULOSIS
- TBAJ-876 retains Bedaquiline's activity against subunit c and ϵ of Mycobacterium tuberculosis F-ATP synthase
- (2019) Jickky Palmae Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting Protein Kinase D and Protein Kinase G
- (2019) Saqib Kidwai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals
- (2019) Jackson Mukonzo et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
- (2019) Edyta M. Grzelak et al. JOURNAL OF ANTIBIOTICS
- An overview of new antitubercular drugs, drug candidates, and their targets
- (2019) Aparna Bahuguna et al. MEDICINAL RESEARCH REVIEWS
- Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes
- (2019) Eachan O. Johnson et al. NATURE
- Management of drug-resistant tuberculosis
- (2019) Christoph Lange et al. LANCET
- Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis
- (2019) Giovanna Poce et al. ACS Medicinal Chemistry Letters
- Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity
- (2019) Manjunatha M. R et al. ACS Medicinal Chemistry Letters
- TBAJ-876 displays Bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity
- (2019) Jickky Palmae Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pretomanid: First Approval
- (2019) Susan J. Keam DRUGS
- hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents
- (2019) Kai Lv et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents
- (2019) Apeng Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials
- (2019) Ludovica Mascolo et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
- (2019) Tiago Beites et al. Nature Communications
- New potential drug leads against MDR-MTB: A short review
- (2019) Srikanth Gatadi et al. BIOORGANIC CHEMISTRY
- In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
- (2018) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis
- (2018) Jérémie Piton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals
- (2018) Lu Xiong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hit Generation in TB Drug Discovery: From Genome to Granuloma
- (2018) Tianao Yuan et al. CHEMICAL REVIEWS
- More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis
- (2018) Amber C Bonds et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis
- (2018) Bei Shi Lee et al. CURRENT OPINION IN PHARMACOLOGY
- Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases
- (2018) Guilherme Felipe dos Santos Fernandes et al. CURRENT PHARMACEUTICAL DESIGN
- An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy
- (2018) Archita Mishra et al. EMBO Molecular Medicine
- In vivo potent BM635 analogue with improved drug-like properties
- (2018) Giovanna Poce et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
- (2018) André Campaniço et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the messengers: Serine/threonine protein kinases as potential targets for antimycobacterial drug development
- (2018) Mehak Zahoor Khan et al. IUBMB LIFE
- Where Do Recent Small Molecule Clinical Development Candidates Come From?
- (2018) Dean G. Brown et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipophilic Efficiency as an Important Metric in Drug Design
- (2018) Ted W. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
- (2018) Rupesh V. Chikhale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB
- (2018) Laura A. T. Cleghorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity
- (2018) Samuel Agyei Nyantakyi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Translational regulation in mycobacteria and its implications for pathogenicity
- (2018) Elizabeth B Sawyer et al. NUCLEIC ACIDS RESEARCH
- IMB-SD62, a triazolothiadiazoles derivative with promising action against tuberculosis
- (2018) Qi Deng et al. TUBERCULOSIS
- Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
- (2018) Diana Machado et al. Frontiers in Microbiology
- The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs
- (2018) Huan Chen et al. Frontiers in Microbiology
- The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
- (2018) Samantha Wellington et al. ACS Infectious Diseases
- An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169)
- (2018) Andréanne Lupien et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors
- (2018) Chao Fang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis
- (2018) Mikhail Krasavin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of novel benzothiopyranone compounds against mycobacterium tuberculosis through scaffold morphing from benzothiazinones
- (2018) Peng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo
- (2018) Clare F. Vickers et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Aspartate-Specific Solute-Binding Protein Regulates Protein Kinase G Activity To Control Glutamate Metabolism in Mycobacteria
- (2018) Nabanita Bhattacharyya et al. mBio
- Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety
- (2018) T.G. Shruthi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis
- (2018) Ana Guardia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors
- (2018) Maciej K. Rogacki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility
- (2018) Bai-Yu Lee et al. PLoS One
- An electron transfer path connects subunits of a mycobacterial respiratory supercomplex
- (2018) Hongri Gong et al. SCIENCE
- Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
- (2018) Pradeep Kumar et al. mBio
- Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
- (2018) Caroline S. Foo et al. mBio
- The Mycobacterial Cell Envelope: A Relict From the Past or the Result of Recent Evolution?
- (2018) Antony T. Vincent et al. Frontiers in Microbiology
- Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis
- (2018) Xiaoyun Lu et al. ACS Infectious Diseases
- Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents
- (2018) Pingxian Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis
- (2017) Amit Kaushik et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
- (2017) Guilherme Felipe dos Santos Fernandes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
- (2017) Subramanyam J. Tantry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases
- (2017) Chee Wei Ang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multidrug and extensively drug-resistant tuberculosis
- (2017) T. Maitre et al. MEDECINE ET MALADIES INFECTIEUSES
- New structural classes of antituberculosis agents
- (2017) Vajinder Kumar et al. MEDICINAL RESEARCH REVIEWS
- A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase
- (2017) Samantha Wellington et al. Nature Chemical Biology
- Opportunities and challenges in phenotypic drug discovery: an industry perspective
- (2017) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420
- (2017) Nicolas Blondiaux et al. SCIENCE
- Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
- (2017) Dirk Bald et al. mBio
- Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
- (2017) Kai Lv et al. ACS Medicinal Chemistry Letters
- Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine
- (2017) Sarah Batson et al. Nature Communications
- The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis
- (2017) Christophe J. Queval et al. Frontiers in Microbiology
- Addressing the Challenges of Tuberculosis: A Brief Historical Account
- (2017) Hussam W. Al-Humadi et al. Frontiers in Pharmacology
- Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
- (2017) Giulia Degiacomi et al. Scientific Reports
- Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
- (2017) Katherine A. Abrahams et al. Scientific Reports
- Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
- (2017) Joana Costa-Gouveia et al. Scientific Reports
- Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane
- (2017) Laura Chiaradia et al. Scientific Reports
- Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee
- (2016) Harald Hoffmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New and Old Hot Drug Targets in Tuberculosis
- (2016) Laurent Roberto Chiarelli et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
- (2016) Guilherme Felipe dos Santos Fernandes et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current challenges in drug discovery for tuberculosis
- (2016) Anuradha Kumar et al. Expert Opinion on Drug Discovery
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- Non-classical transpeptidases yield insight into new antibacterials
- (2016) Pankaj Kumar et al. Nature Chemical Biology
- Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target
- (2016) KATHERINE A. ABRAHAMS et al. PARASITOLOGY
- Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
- (2016) Subramanyam J. Tantry et al. MedChemComm
- Identification of KasA as the cellular target of an anti-tubercular scaffold
- (2016) Katherine A. Abrahams et al. Nature Communications
- Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
- (2016) Dirk A. Lamprecht et al. Nature Communications
- Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
- (2016) Scott M. Irwin et al. ACS Infectious Diseases
- Prediction of Drug Penetration in Tuberculosis Lesions
- (2016) Jansy P. Sarathy et al. ACS Infectious Diseases
- Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB
- (2016) Garrett C. Moraski et al. ACS Infectious Diseases
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
- (2016) María Martínez-Hoyos et al. EBioMedicine
- Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
- (2016) Chao Gao et al. Scientific Reports
- Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus
- (2015) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets
- (2015) Guilherme dos Santos Fernandes et al. CURRENT MEDICINAL CHEMISTRY
- Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
- (2015) S. M. Irwin et al. Disease Models & Mechanisms
- Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
- (2015) J.-P. Lanoix et al. Disease Models & Mechanisms
- The future for early-stage tuberculosis drug discovery
- (2015) Edison S Zuniga et al. Future Microbiology
- Synthesis and Structure–Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2015) Brian D. Palmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hit and lead criteria in drug discovery for infectious diseases of the developing world
- (2015) Kei Katsuno et al. NATURE REVIEWS DRUG DISCOVERY
- Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents
- (2015) Jian Tang et al. ACS Medicinal Chemistry Letters
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
- (2015) K. Mdluli et al. Cold Spring Harbor Perspectives in Medicine
- Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment
- (2015) Brian C. VanderVen et al. PLoS Pathogens
- Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery
- (2015) María Jose Rebollo-Lopez et al. PLoS One
- Structure, Biochemistry, and Inhibition of Essential 4′-Phosphopantetheinyl Transferases from Two Species of Mycobacteria
- (2014) Christopher R. Vickery et al. ACS Chemical Biology
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
- (2014) Monalisa Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Folate Pathway Disruption Leads to Critical Disruption of Methionine Derivatives in Mycobacterium tuberculosis
- (2014) Molly R. Nixon et al. CHEMISTRY & BIOLOGY
- Delamanid: First Global Approval
- (2014) Nicola J. Ryan et al. DRUGS
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Tuberculosis drug discovery in the post-post-genomic era
- (2014) Benoit Lechartier et al. EMBO Molecular Medicine
- The early bactericidal activity of antituberculosis drugs
- (2014) Andreas H Diacon et al. Expert Review of Anti-Infective Therapy
- Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
- (2014) Suresh B. Lakshminarayana et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Totally drug-resistant tuberculosis and adjunct therapies
- (2014) S. K. Parida et al. JOURNAL OF INTERNAL MEDICINE
- New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
- (2014) Mikhail F. Gordeev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
- (2014) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
- (2014) Robert S. Wallis et al. PLoS One
- Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
- (2014) Ashish Kumar Kakkar et al. TUBERCULOSIS
- In VitroCross-Linking of Mycobacterium tuberculosis Peptidoglycan by l,d-Transpeptidases and Inactivation of These Enzymes by Carbapenems
- (2013) Mathilde Cordillot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis
- (2013) Giovanna Riccardi et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Feast or famine: the host-pathogen battle over amino acids
- (2013) Yanjia J. Zhang et al. CELLULAR MICROBIOLOGY
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology: A mortal foe
- (2013) Tom Paulson NATURE
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
- (2013) Giovanna Poce et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
- (2013) S. K. Hatzios et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
- (2013) S. A. Stanley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates
- (2012) Meenakshi Balganesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
- (2012) Emily R. Driver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis
- (2012) Dongfeng Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
- (2012) J. Neres et al. Science Translational Medicine
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
- (2011) Yu Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1
- (2011) Pedro Eduardo Almeida da Silva et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Challenges and opportunities in developing novel drugs for TB
- (2011) Takushi Kaneko et al. Future Medicinal Chemistry
- Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review
- (2011) Edine W. Tiemersma et al. PLoS One
- Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
- (2010) J. Rullas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
- (2010) Takahiro Yano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mycobacterial survival strategies in the phagosome: defence against host stresses
- (2009) Sabine Ehrt et al. CELLULAR MICROBIOLOGY
- Requirements for a lead compound to become a clinical candidate
- (2008) Franz F Hefti BMC NEUROSCIENCE
- Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
- (2008) Matthew E Falagas et al. DRUG SAFETY
- A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents
- (2008) J. G. Hurdle et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
- (2008) Paul S. Charifson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Detection and Molecular Characterization of 9000-Year-Old Mycobacterium tuberculosis from a Neolithic Settlement in the Eastern Mediterranean
- (2008) Israel Hershkovitz et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now